Studies on human papillomavirus type 16 have demonstrated that the product of the early gene, E7, plays a key role in the immortalization and malignant transformation of the host cell. Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 and p130. In this study, we have characterized the in vitro properties of ®ve E7 proteins from benign and malignant HPV types (10, 32, 48, 54, 77). We show that these E7 proteins associate with pRb and p107 with dierent eciencies. All E7s increased the proliferative rate of immortalized rodent ®broblasts cultured in 10% calf serum containing medium. This property is completely independent of their ability to associate with the pocket proteins. Furthermore, all E7s, except HPV10 E7, stimulate G1/S progression and activated the cyclin E and cyclin A promoter in the absence of growth factors. This activity also does not correlate with the E7-eciency of binding the pocket proteins. Together these data provide evidence that dierent E7s alter the regulation of the cell cycle by diverse mechanism(s). Finally, this comparative analysis of the dierent E7 proteins demonstrates that the oncogenicity of a HPV type is not determined by the ability of E7 to associate with the pocket proteins. Oncogene (2000) 19, 821 ± 826.
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Keywords: human papillomaviruses; E7 proteins; pocket proteins; S phase induction Eighty-three human papillomavirus genotypes have been fully characterized so far (de Villiers, 1997) . They vary in tissue distribution, oncogenic potential and association with anatomically and histologically distinct diseases (zur Hausen, 1996) . Based on the ability to infect the skin or mucosa of the anogenital and respiratory tracts, the HPVs fall into two groups, cutaneous and mucosal genotypes (de Villiers, 1997) . Lesions induced by dierent anogenital HPV types reveal substantial variations in their risk for malignant progression. Thus, the anogenital HPV types are further subdivided into two groups:`high risk' viruses, comprising HPV types 16 and 18 regularly found in cervical cancer biopsies, and`low risk' viruses 6 and 11 types, which are only rarely found in malignant tumours (zur Hausen, 1991) .
The products of two early viral genes, E6 and E7, play a key role in induction of transformation of the host cells. Both viral proteins exert their biological activity by interacting with and inactivating a number of cellular proteins (Tommasino and Crawford, 1995) . E7 of the`high risk' HPV16 is able to maintain cells in cycle in the absence of growth factors, to induce anchorage-independent growth in a variety of established rodent ®broblast lines and to co-operate with E6 to immortalize primary human keratinocytes (Mansur and Androphy, 1993; Jansen-DuÈ rr, 1996) . These activities are in part explained by the ability of E7 to associate through its LXCXE motif (amino acids 22 ± 26 in HPV16 E7), with the members of the pocket protein family, pRb, p107 and p130 (Dyson et al., 1989; Davies et al., 1993; Hu et al., 1995) . The pocket proteins are involved in controlling cell cycle progression. They negatively regulate, via direct association, the activity of several transcription factors, including members of the E2F family (Lavia and Jansen-DuÈ rr, 1999) . The association of E7 with the pocket proteins results in the release of E2Fs, which in turn activate transcription of a group of genes encoding key proteins for S phase progression, like cyclin E or A (Lavia and Jansen-DuÈ rr, 1999) . Point mutation analysis of HPV16 E7 protein revealed that the integrity of its pRbbinding domain, LXCXE, is essential for its biological activity (Phelps et al., 1992) . However, the data available so far do not provide any evidence whether the pocket binding domain is equally important in E7s from dierent HPV types for their biological functions. Indeed, some E7 proteins are partly or completely devoid of the pocket protein-binding domain (Tommasino, 1997) . Thus, it is likely that certain HPV types have developed a dierent mechanism to induce cellular proliferation. To test this hypothesis we have performed a comparative analysis of several uncharacterized E7 proteins. In particular, we address the question of whether the eciency of each E7 protein to associate with pRb and p107 correlates with a speci®c in vitro biological activity. As indicated in Table 1, E7 proteins from HPV10, 32, 48, 54, 77 were included in this study. The proteins were selected on the basis of the nature of the lesions induced by the HPV genotype and the features of the E7 primary structure, e.g. presence or absence of pRb binding domain. Since several of the biological properties of HPV16 E7s have been extensively characterized (Mansur and Androphy, 1993) , this protein was also included as reference. The ability of dierent E7 proteins to associate with pRb and its related protein p107 was analysed in the Saccharomyces cerevisiae`two hybrid' system. Previous studies have demonstrated the validity of this method for the determination of E7 binding anity for pRb (Ciccolini et al., 1994; Clemens et al., 1995) . The E7 genes were cloned into the pSD.06 vector, in which they were fused with the C-terminal transcription activation domain of the VP16 protein (Dalton and Treisman, 1992) . pRb and p107 were cloned into the pTSRF vector in frame with the DNA binding domain of the serum response factor (SRF) (Dalton and Treisman, 1992 ). An hemaglutinin epitope (HA-tag) was added at the N-terminal of each E7 to enable determination of the intracellular levels of the viral proteins by western blot analysis. The S. cerevisiae 62L strain was transformed with DNA constructs in dierent combinations as indicated in Figure 1a ,b. Yeast cells were grown in galactose media since the transcription of chimeric genes, E7/VP16 and pRb/ SRF or p107/SRF, are under the control of a galactose inducible promoter. After 10 ± 12 h total protein extracts were prepared and the b-galactosidase activity was measured (Ciccolini et al., 1994) . Western blot analysis using a speci®c anti HA-tag antibody revealed that HPV10, 16 and 77 E7s are expressed at similar levels, whilst HPV48 E7 is highly expressed. In contrast, HPV32 and 54 E7s were present in the yeast cell extracts at low concentrations ( Figure 1c and data not shown). In the case of HPV54 E7, only a faint protein band was detected by Western blot analysis ( Figure 1c and data not shown). The pattern of E7 expression was highly reproducible, since similar levels of each E7 protein were observed in independent yeast clones. Taking in consideration the Western blot and the two hybrid system data we can conclude that HPV16, 32, 54 and 77 E7s are able to bind the pocket proteins. On the contrary, HPV10 and 48 E7s do not associate with pRb and p107 (see Figure 1a ,b). As negative control, we co-transformed the yeast cells with pTSRF and pSD.06-E7 vectors or pTSRF-pRb and pSD.06 vectors, which do not transactivate the reporter gene ( Figure 1a ,b, and data not shown). To further con®rm that HPV10 and 48 E7 do not associate with pRb, we have performed a GST pull-down assay. HPV10, 16, 32 and 48 GST fusion proteins were immobilized on Glutathione-Sepharose beads and incubated with nuclear protein extracts of immortalized human keratinocytes (HaCat). As negative control, the GST and a GST/HPV16 E7 protein mutagenised in the pRb binding site (C substitution to G in position 24) were included in the assay (Davies et al., 1993) . As shown in Figure 2 , HPV16 E7 wild-type and HPV32 E7 are able to interact with pRb. In contrast, only a faint pRb band was observed in the negative control (HPV16 E7 G24) and HPV10 and 48 E7s. Thus the GST pull-down assay con®rmed the yeast two-hybrid results. These data are in agreement with the fact that the pRb binding domain, LXCXE, is partially or completely missing in E7 of HPV10 and 48 (see Table 1 ).
Next, we compared the biological activities of the dierent E7s in rodent immortalized ®broblasts. For this purpose, both the native and the N terminally tagged forms of the E7 genes were cloned into the retroviral vector pBabe-puro, in which the expression of the heterologous gene is driven by the Mo MuLV Long Terminal Repeat (LTR). In addition, the plasmid contains a second transcriptional unit that confers resistance to puromycin (Morgenstern and Land, 1990) . High titre recombinant retroviruses were generated by transient transfection of the BOSC23 ecotropic producer cell line (Pear et al., 1993) and used to infect NIH3T3 cells. After 48 h of selection in puromycin (2 mg/ml), resistant clones were pooled and used for the determination of E7 biological properties. To avoid the possibility of chromosomal instability due to in vitro manipulation, all the experiments described here were performed with cells that were not cultured for more than six passages. The expression of the proteins in the transient cell lines was tested by immunoblotting using an antibody raised against the HA epitope (MMS-101R Babco). As can be seen in Figure 3 , most of the E7 proteins are expressed at similar levels, with the exception of HPV32 and 54 E7, which are, as in the yeast system, present at lower concentrations. Like in yeast, also in mammalian cells, the pattern of E7 expression was similar in independent experiments. These results indicate that the low expression of HPV32 and 54 is due to intrinsic properties of the molecules and is independent of the expression system used. Studies on HPV16 and 18 E7 proteins show that the C-terminal region, comprised of two cys-x-x-cys (CXXC) motifs, is important for the stability of the molecule. Substitution of one of the cysteines or a length variation of the domain between the two CXXC motifs results in a destabilization of the protein (Watanabe et al., 1992; McIntyre et al., 1993) . In one of the cysteine motifs in HPV54 E7 the two cysteines are separated by three amino acids instead of two (CXXXC) and the spacer region between the CXXC motifs is 30 amino acids long, instead of 29 as in the majority of other E7 proteins. Thus, the structure of the C-terminal region of HPV54 E7 may be responsible for its low expression levels. After determination of the intracellular levels of the dierent E7 proteins, we analysed their biological activity. Studies on HPV16 E7 protein showed that the presence of the HA-tag at the N-terminal region does not in¯uence its properties (our unpublished data). However to exclude the possibility that the fusion of the HA-tag to the E7 proteins analysed in this study could alter their functions, all experiments were performed with cell lines expressing the native E7 or E7 HA-tag from each HPV type. In all cases, the results obtained were similar, indicating that the HAtag did not alter the activity of any of the E7s (data not shown). We observed that E7-NIH3T3 cells have a shorter doubling time than the control cells in DMEM containing 10% CS. Therefore, to determine their proliferative rate, we analysed the pro®le of cell cycle phases in the cell lines expressing the dierent E7 genes. Cells grown in DMEM 10% CS were ®xed and stained with propidium iodide for determination of cell cycle phases by¯ow cytometry analysis. As can be seen in Figure 4a , all cell lines expressing the E7 genes have a higher percentage of S phase cells than the NIH3T3 cells. These data indicate that the property of E7 proteins to stimulate proliferation in NIH3T3 cells is independent of their ability to associate with pocket proteins, since HPV10 and 48 E7 do not bind pRb and p107. To further con®rm these ®ndings we have determined the proliferative rate of the cells expressing E7s by an alternative method, bromo-uridine incorporation (Figure 4b ). In addition, we checked whether the HPV16 E7 C24G mutant, which does not associate with pRb and p107 (Figure 2 and Davies et al., 1993) , retains the property to stimulate proliferation of cells cultured in DMEM 10% CS. Also in this assay, cells expressing any of the E7 proteins, including the HPV16 E7 C24G mutant, have a higher proliferative rate than the control cells (Figure 4b) . Thus, direct association with pRb and p107 does not mediate the E7-stimulated proliferation in growth medium supplemented with 10% CS.
It has been shown that immortalized rodent ®broblasts expressing the HPV16 E7 protein acquire the ability to enter S phase in the absence of serum growth factors and to grow in an anchorageindependent manner (Mansur and Androphy, 1993; Zerfass et al., 1995) . Therefore, we examined whether the other E7 proteins also retain any of these HPV16 E7 functions and whether these biological properties are mediated by the pocket proteins association. Again, Figure 2 GST/E7 pull down assays. The E7 genes of the dierent HPV types indicated in the ®gure were cloned in the pGEX4T vector (Pharmacia) in frame to the carboxy-terminal domain of the Schistosoma japonicum glutathione S-transferase (GST). The fusion proteins were expressed in the bacteria DH5a and puri®ed by single step chromatography on Glutathionesepharose according to the manufacturer's instructions. 1 mg of the dierent GST proteins were immobilized on Glutathione and incubated with 300 mg of nuclear protein extract of HaCat cells. After 1 h, the beads were extensively washed and directly resuspended in SDS-sample buer. The amount of pRb associated with the dierent GST/E7 proteins was determined by Western blot analysis using a speci®c anti pRb antibody (14001A, Pharmigen) NE: 150 mg of nuclear extract Figure 3 Expression levels of E7 proteins in NIH3T3 cells. Total protein extracts were prepared as described in (Ciccolini et al., 1994) . 100 mg of protein extract were fractionated on a 12% polyacrilamide-SDS gel, transferred to PVDF membrane and incubated with an anti HA-tag monoclonal antibody (MMS-101R, Babco, 1/1000) or a monoclonal anti b-tubulin antibody as loading control (clone tub2.1, Sigma, 1/1000) Figure 1 Association of E7 proteins with pRb (a) or p107 (b) in yeast two hybrid system. E7 genes from HPV types 10, 16, 32, 48, 54 and 77 were fused to the C-terminal transcription activation domain of the VP16 protein. pRb (a) and p107 (b) were fused to the DNA binding domain of the serum response factor (SRF). Both fused genes were cotransformed into S. cereviseae 62L by lithium acetate procedure. Empty vector is a negative control with pRb or p107 in pTSRF and empty pSD.06. The results are the mean of three independent experiments. (c) Expression levels of E7 proteins in S. cereviseae. Total protein extracts were prepared by disrupting mid-log phase yeast cells expressing the dierent E7 proteins with glass-beads. 50 mg of protein extract were fractionated on a 12% polyacrilamide-SDS gel, transferred to PVDF membrane and incubated with an anti HA-tag monoclonal antibody (MMS-101R, Babco, 1/1000) the HPV16 E7 C24G mutant was included as a negative control since it does not induce S phase in the absence of growth factors (Banks et al., 1990) . The NIH3T3 cells expressing the dierent E7 proteins were grown in DMEM containing 0.5% CS for 48 h. The percentage of cells in S phase was determined by¯ow cytometry ( Figure 5 ). This assay reveals that only HPV10 E7 is unable to release the cells from the arrest imposed by serum deprivation. In contrast HPV16, 32, 48, 54 and 77 E7s stimulate G1/S progression in the absence of growth factors, although with dierent eciencies (Figure 5 ). HPV 16 E7 resulted to be the most active protein in this assay. Also in this case, the ability of E7 to induce S phase upon serum deprivation does not correlate with the eciency in binding pRb (see Figures 1a,b and 5) . The most striking evidence can be observed in the behaviour of HPV48 E7 expressing cells. HPV48 E7 induces S phase of NIH3T3 cells in the absence of growth factors despite the fact that it does not associate with pRb and p107.
The G1/S progression normally requires transcriptional activation of several genes, e.g. cyclin E and A, which are positively regulated by members of the E2F family. HPV16 E7 activates these transcription factors by neutralizing the pocket proteins. To test whether the S phase entry induced by the dierent E7s in serum deprived cells is mediated by activation of E2F-driven transcription, we determined their ability to activate the cyclin E and A promoter. The pBabe-E7 constructs were co-transfected with a vector containing the luciferase reporter gene under the control of cyclin E or A promoter (Botz et al., 1996; Schulze et al., 1995) . As shown in Figure 6 , the pattern of activation of both promoters by the E7s correlates with their ability to induce S phase in serum deprived cells. HPV48 E7 is able to activate cyclin E and A promoters, although with lower eciency than HPV16 E7. The fact that HPV48 E7 does not associate with pRb and p107 suggests that this protein has a mechanism distinct from the one of HPV16 E7 in activating cyclin E and A promoters. On the contrary, HPV77 E7, which interacts with the pocket proteins, is able to weakly stimulate S phase entry and activate cyclin promoters. Studies on HPV16 E7 protein have demonstrated that two distinct E7 domains, the LXCXE motif and the last 50 C-terminal amino acids (Wu et al., 1993) mediate the E2F/pRb dissociation. Thus, it is likely that the dierence between HPV16 and 77 E7s in the induction of S phase entry and activation of cyclin promoters is related to dierent properties of the Cterminal region.
Another property of HPV16 E7 is to induce anchorage independent growth (Mansur and Androphy, 1993). Therefore we determined the ability of NIH3T3 cells expressing the dierent E7s to grow in soft agar. Cells were seeded on soft agar plates, grown for 4 weeks and resultant colonies counted (Figure 7) . Only HPV16, 32 and 77 E7s are able to induce anchorage-independent growth in soft agar plates. These E7s associate with the pocket proteins, indicating that the strength of the E7/pRb or E7/p107 interaction has a key role in inducing anchorageindependent growth. The failure of HPV54 E7 to induce colony formation in soft agar may be due to its low expression, since we observed that the growth rate in soft agar correlates with intracellular levels of E7.
In summary, in this study we have characterized some of the biological activities of several E7 proteins from dierent HPV types. We show that all the tested E7 proteins have the ability to stimulate proliferation in immortalized rodent ®broblasts cultured in 10% CS medium. Most importantly, this E7 property is independent of the binding to pRb. Indeed, E7s with dierent eciency in binding pRb and p107 are able to increase the growth rate approximately to the same extent. These data are further corroborated by the fact that the HPV16 E7 C24G mutant, which does not associate with the pRb, is still capable of stimulating proliferation in cells cultured in medium containing 10% CS. These data demonstrate the existence of an additional E7-mechanism to promote proliferation, which co-operates with the neutralization of E2F pathway. In contrast, not all E7 proteins are able to overcome a G1 arrest imposed by serum deprivation. HPV16, 32, 48, 54, 77 E7s, but not HPV10 E7, are able to transactivate the cyclin A and E promoters and to maintain cells in cycle in a medium containing 0.5% serum. Also in this case, the induction of S entry does not always correlate with the E7 ability to associate with pRb. The fact that HPV48 E7 promotes S phase in serum deprived cells without associating with pRb and p107 indicates that this E7 acts via alternative pathway(s) to transactivate the cyclin promoters and induce S phase. However, our data do not exclude the possibility that HPV48 E7 inactivates pRb functions indirectly by binding to other unknown pRb-associated factors. In contrast to the other E7 activities, the stimulation of anchorage independent growth appears to be related to the eciency in binding pRb and p107. HPV16, 32 and 77 E7s bind pRb and they are able to transform rodent ®broblasts, as assayed by the formation of soft agar colonies. This study also shows that HPV32 and 54 E7 proteins display in several assays a comparable activity to HPV16 E7. Taking in consideration that both E7s are expressed at lower levels than HPV16 E7, we can hypothesise that HPV32 and 54 E7s are more active than the other E7 proteins.
It has been previously reported that a strong E7/ pocket protein association is not sucient to determine the oncogenicity of the HPV type (Ciccolini et al., 1994; Schmitt et al., 1994) . HPV1 and 16 E7 proteins bind pRb with similar eciency, although HPV1 is a benign type, normally associated with common warts. Analogously to HPV1 E7, HPV 32 E7 is also able to strongly associate with the pocket proteins and yet this mucosal genotype has, to our knowledge, not been found in malignant lesions. In contrast, HPV 10 and 48 have been detected in cell squamous carcinomas (Muller et al., 1989; Storey et al., 1998) , despite the fact that their E7 proteins do not interact with pRb and p107. Taking in consideration the previous published data and the results obtained in this study we can conclude that there is no obvious correlation between E7/pRb association and the oncogenicity of the HPV type. Thus, factors that determine the malignancy of an HPV type must reside in other domains of E7 or alternatively in other viral proteins. In the case of bovine papillomaviruses, E5 and E6 are the major transforming proteins. Therefore, it is likely that in certain HPV types, these proteins may have key roles in malignant transformation. Overall, this study demonstrates that, despite the fact that the main characteristics are conserved throughout the HPV genomes, the E7 mechanism(s) of inducing proliferation or transformation dier largely. However, considering the tropism speci®city and the diverse spectrum of lesions caused by these viruses the fact that they have dierent mechanisms of action is not surprising. Figure 6 Ability of the E7 proteins to transactivate the cyclin E and A promoters. The dierent pBabe-puro vectors expressing E7 proteins were cotransfected together with a construct containing cyclin E (a) or cyclin A (b) promoter cloned in front of the luciferase gene. Sixteen hours post-transfection cells were cultured in medium containing 0.5% FCS. After 24 h the cells were lysed and luciferase activity was determined. Luciferase activity was normalised to b-galactosidase activity obtained from a cotransfected cytomegalovirus-driven b-galactosidase plasmid. The data are the mean of three independent experiments Figure 7 Ability of dierent E7 proteins to induce anchorageindependent growth. Cells were seeded in soft agar plates (0.28% low melting agarose in DMEM 10% CS), grown for 4 weeks and the number of colonies was counted. Data are expressed as percentage in respect to the number of colonies induced by HPV16 E7. The results are the mean of three independent experiments, each performed in duplicate their co-operation, Dr Pidder Jansen-DuÈ rr for the plasmids containing cyclin E and A promoters and Dr Leonie Ringrose for her constructive comments on the manuscript.
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